AVB
67
2
SHW
68
-5
VMC
60
-2
MAT
41
-4
MMC
67
2
CME
64
5
SWK
67
-4
CMS
64
4
MUR
42
-2
EXPE
93
2
CI
63
7
DG
6
-4
IRM
52
2
HSIC
60
-2
PYPL
56
-4
NEE
59
5
MOS
43
-5
NVDA
54
2
HBI
59
4
ZION
69
-2
AVB
67
2
SHW
68
-5
VMC
60
-2
MAT
41
-4
MMC
67
2
CME
64
5
SWK
67
-4
CMS
64
4
MUR
42
-2
EXPE
93
2
CI
63
7
DG
6
-4
IRM
52
2
HSIC
60
-2
PYPL
56
-4
NEE
59
5
MOS
43
-5
NVDA
54
2
HBI
59
4
ZION
69
-2
Financhill
Back

Pharmaron Beijing 10K Form

Sell
19

PHBBF
Pharmaron Beijing

Last Price:
1.93
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PHBBF News And Ratings

See the #1 stock for the next 7 days that we like better than PHBBF

PHBBF Financial Statistics

Sales & Book Value

Annual Sales: $1.53B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.24
Price / Book: 0

Profitability

EPS (TTM): 0.18150
Net Income (TTM): $214.73M
Gross Margin: $561.02M
Return on Equity: 0%
Return on Assets: 0%

Pharmaron Beijing Earnings Forecast

Key Pharmaron Beijing Financial Ratios

  • The Gross Profit Margin over the past 9 years for PHBBF is 36.71%.
  • The Selling, General & Administrative Expenses for PHBBF have been equal to 9.44% of Gross Profit Margin.
  • The Research & Development expenses have been 2.75% of Revenue.
  • The Interest Expense is 12.17% of Operating Income.
  • The Net Earning history of PHBBF is 13.39% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Pharmaron Beijing Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: PHBBF
Website: pharmaron.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PHBBF Technical Analysis vs Fundamental Analysis

Sell
19
Pharmaron Beijing (PHBBF) is a Sell

Is Pharmaron Beijing a Buy or a Sell?